Stockhouse.com and BioMark Interview About Early Cancer Detection Podcast - Biomark Diagnostics

Articles and Information

June 21, 2016

Stockhouse.com and BioMark Interview About Early Cancer Detection Podcast

BioMark Diagnostics Inc.

BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

Interview with BioMark CEO Rashid Ahmed about the importance of early cancer detection and details of how the BioMark technology works. [podcast_episode episode=”2159″ content=”title,excerpt,player”]

Share this post:

Categories

Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.

CSE: BUX
OTC: BMKDF
FSE: 20B

More Information

Investors

Related articles ...

biomark-press-release

News

BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection

January 18, 2026

biomark-progress-report

Articles and Information

Form 7 Monthly Progress Report December 2025

Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of

January 5, 2026

biomark-press-release

News

BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors

BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors Expanding U.S. market

January 3, 2026

biomark-press-release

News

BioMark: 2025 Achievements & 2026 Vision

BioMark: 2025 Achievements & 2026 Vision Celebrating A Year of Extraordinary Achievement VANCOUVER, BRITISH COLUMBIA

January 2, 2026

biomark-press-release

News

BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program Company engages Standards Council

December 24, 2025

1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2

Pages

Latest Posts

Site Policies

© 2024 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.